Liang Feng

机构：Nanjing University of Chinese Medicine, China Pharmaceutical University, First Affiliated Hospital of Liaoning Medical University, First Hospital of Shijiazhuang, Oil Crops Research Institute · ORCID：0000-0002-2154-5670

发表论文 104 篇 · 总被引 506 次 · h-index 12

代表论文

• RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway (2023 · Brain · 被引 74)
• Microwave ablation versus liver resection for primary intrahepatic cholangiocarcinoma within Milan criteria: a long-term multicenter cohort study (2024 · EClinicalMedicine · 被引 25)
• Engineered plant extracellular vesicles: Emerging nanoplatforms for combinational cancer immunotherapy (2025 · Acta Pharmaceutica Sinica B · 被引 24)
• Carbon nanotubes-functionalized MgO-based castables: Super-nonwetting behavior and slag corrosion resistance (2024 · Construction and Building Materials · 被引 22)
• Recent advances in the reciprocal regulation of m6A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia (2024 · Pharmacology & Therapeutics · 被引 6)
• Effect of h-BN rods on high-temperature properties of alumina–carbon refractory (2024 · Journal of Iron and Steel Research International · 被引 5)